Search for: "Rushing v. Merck " Results 1 - 15 of 15
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Jul 2011, 3:33 pm
207/10, Orifarm v Merck Sharpe & Dohme; Paranova v Merck Sharp & Dohme, sped through in pretty good time. [read post]
8 Nov 2018, 3:04 am
For practitioners the message was that whilst there may be a grace period for adjustments post-Brexit, it may be wiser to take action now in order to avoid issues such as being unable to service clients, and the rush to meet EUIPO guides that will likely incur high costs.The Keynote: Key Trade Mark Cases of the Last 12 monthsBenet Brandreth QC (11 South Square) gave an enthusiastic review of some of the most interesting Trade Mark cases in the last 12 months; such as Cartier v B… [read post]
26 Aug 2009, 6:12 am
F. of L. files antitrust suit against Merck, alleging fraudulent procurement of a patent, improper listing of patent in Orange Book (Patent Docs) Singulair (Montelukast) – US: Merck get injunction preventing Teva from selling generic Montelukast: Merck Sharp & Dohme Pharmaceuticals SRL v Teva Pharmaceuticals USA (The IP Factor) (IP Watchdog) (SmartBrief) (SmartBrief) (GenericsWeb)   [read post]
9 Aug 2012, 5:00 am by Bexis
Merck (Vioxx) Trial2006-05-08 Doherty v. [read post]
2 Mar 2012, 6:52 am by Bexis
Merck (Vioxx) Trial2006-05-08 Doherty v. [read post]
2 Oct 2008, 12:36 pm
Merck & Co., 2006 WL 3302574, at *3 & n.2 (S. [read post]
17 Aug 2011, 5:00 am by Bexis
Merck & Co., ___ F.3d ___, 2011 WL 3375104 (2d Cir. [read post]
13 Jun 2008, 3:40 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: ECJ rules trade mark holders cannot stop honest comparative advertising: O2 Holdings Limited and O2 (UK) Limited v Hutchinson 3G UK Limited: (Out-Law), (Catch Us If You Can!!!) [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ that its… [read post]
27 Mar 2019, 1:00 am by Thaddeus Mason Pope, JD, PhD
Here is the schedule for the 2019 Health Law Professors Conference. [read post]